香港交易及結算所有限公司及香港聯合交易所有限公司及新加坡證券交易所有限公司對本公 告之內容概不負責，對其準確性或完整性亦不發表任何聲明，並表明不會就因本公告全部或 任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司任何證券的邀請或要約。 Concord New Energy Group Limited 協 合 新 能 源 集 團 有 限 公 司 * （ 於 百 慕 達 註 冊 成 立 之 有 限 公 司 ） 有關建議於新加坡證券交易所第二上市之預計上市日期 本公告乃由Concord New Energy Group Limited（協合新能源集團有限公司*）（「本公司」，連 同其附屬公司，統稱「本集團」）根據香港聯合交易所有限公司（「聯交所」）證券上市規則第 13.09(2)(a)條以及證券及期貨條例（香港法例第571章）第XIVA部而作出。 茲提述以下於聯交所刊發之公告（統稱「該等公告」）：本公司日期為二零二五年二月二十七 日，內容有關建議於新交所主板第二上市之公告、本公司日期為二零二五年十二月二十三 日，內容有關接獲新交所之上市資格函之公告，以 ...

协合新能源发布公告，本公司已于2025年12月23日接获新交所就建议第二上市发出的上市资格函（上市 资格函）。上市资格函并非对于建议第二上市、本集团及/或本公司股票价值的指示。建议第二上市将 不会涉及发行新股或其他集资活动。本公司的已发行普通股于其后将继续主要于联交所上市及买卖。 此前，中国证监会国际合作司发布关于协合新能源境外发行上市的备案通知书。根据通知书内容，该公 司拟通过介绍方式在新加坡证券交易所实现上市，标志着其国际化资本运作取得阶段性进展。市场分析 指出，新加坡作为亚太地区重要的金融中心，在绿色能源领域资本配置方面具有独特优势，此次上市或 为公司引入更多国际长期资本，支持其可再生能源业务的全球化布局。 协合新能源（00182）午前股价上涨3.23%，现报0.32港元，成交额494.56万港元。 来源：新浪港股 ...

消息面上，协合新能源发布公告，本公司已于2025年12月23日接获新交所就建议第二上市发出的上市资 格函(上市资格函)。上市资格函并非对于建议第二上市、本集团及/或本公司股票价值的指示。建议第二 上市将不会涉及发行新股或其他集资活动。本公司的已发行普通股于其后将继续主要于联交所上市及买 卖。 此前，中国证监会国际合作司发布关于协合新能源境外发行上市的备案通知书。根据通知书内容，该公 司拟通过介绍方式在新加坡证券交易所实现上市，标志着其国际化资本运作取得阶段性进展。市场分析 指出，新加坡作为亚太地区重要的金融中心，在绿色能源领域资本配置方面具有独特优势，此次上市或 为公司引入更多国际长期资本，支持其可再生能源业务的全球化布局。 协合新能源(00182)涨超3%，截至发稿，涨3.23%，报0.32港元，成交额468.59万港元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並表明不會就因本公告全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司任何證券的邀請或要約。 Concord New Energy Group Limited 協 合 新 能 源 集 團 有 限 公 司 * （ 於 百 慕 達 註 冊 成 立 之 有 限 公 司 ） （股份代碼：182） 海外監管公告 介紹文件 本公告乃由Concord New Energy Group Limited（協合新能源集團有限公司*）（「本公司」）根據 香港聯合交易所有限公司證券上市規則第13.10B條而作出。 請參閱附件，該文件為本公司於二零二五年十二月二十六日就有關建議於新加坡交易所證券 交易有限公司（「新交所」）進行本公司已發行普通股第二上市，在新交所網站上刊發的介紹文 件。 承董事會命 Concord New Energy Group Limited 協合新能源集團有限公司* 主席 劉順興 香港，二零二五年十二月二十九日 於本公告日期，董事會成員 ...

Core Viewpoint - The company, Xiehe New Energy (00182), has received a listing eligibility letter from the Singapore Exchange regarding its proposed secondary listing, which is not an indication of the value of the company or its shares [1] Group 1 - The proposed secondary listing will not involve the issuance of new shares or any fundraising activities [1] - The company's issued ordinary shares will continue to be primarily listed and traded on the Hong Kong Stock Exchange [1]

智通财经APP讯，协合新能源(00182)发布公告，本公司已于2025年12月23日接获新交所就建议第二上市 发出的上市资格函(上市资格函)。上市资格函并非对于建议第二上市、本集团及/或本公司股票价值的指 示。 建议第二上市将不会涉及发行新股或其他集资活动。本公司的已发行普通股于其后将继续主要于联交所 上市及买卖。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並表明不會就因本公告全部或任何部份內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司任何證券的邀請或要約。 董事會欣然宣佈，本公司已於二零二五年十二月二十三日接獲新交所就建議第二上市發出之 上市資格函（「上市資格函」）。上市資格函並非對於建議第二上市、本集團及╱或本公司股票 價值之指示。 建議第二上市將不會涉及發行新股或其他集資活動。本公司之已發行普通股於其後將繼續主 要於聯交所上市及買賣。 本公司將於必要時根據適用法律及法規就建議第二上市作出進一步公告。 - 1 - Concord New Energy Group Limited 協 合 新 能 源 集 團 有 限 公 司 * （ 於 百 慕 達 註 冊 成 立 之 有 限 公 司 ） （股份代碼：182） 內幕消息 有關建議於新加坡證券交易所第二上市之更新 本公告乃由Concord New Energy Group Limited（協合新能源集團有限公司*）（「本公司」，連 同其附屬公司，統 ...

Core Viewpoint - The collaboration between insurance funds and renewable energy assets is creating a new investment model that combines industry expertise, financial support, and professional management, aiming for sustainable development in the renewable energy sector [1][5][6]. Group 1: Investment Initiatives - China Life Insurance has invested 9 billion yuan in Qinghai Huanghe Company to support the construction of the world's largest photovoltaic power plant, demonstrating a successful synergy between long-term insurance funds and stable renewable energy assets [1]. - A new renewable energy investment fund with a total scale of 1.811 billion yuan has been established by Xiehe New Energy Group and Taikang Insurance, marking a shift from traditional industry funds to deeper involvement of insurance capital in renewable energy investments [1][5]. Group 2: Financial Performance - Xiehe New Energy reported a 6.6% decline in revenue to 1.4 billion yuan and a 43.8% drop in net profit attributable to shareholders to 282 million yuan in the first half of 2025, highlighting the challenges faced by the company [2][3]. - The average on-grid electricity price for wind power decreased by 4.8%, while for photovoltaic power, it fell by 9.2%, contributing to the company's financial struggles [2][3]. Group 3: Strategic Shift - Xiehe New Energy is transitioning from a heavy asset model of "power station investment and operation" to a lighter asset model of "professional asset management" to ensure sustainable development amid industry challenges [4][6]. - The collaboration aims to address two core issues in the renewable energy sector: acquiring and nurturing quality assets and matching them with long-term stable funding [6][8]. Group 4: Market Dynamics - The renewable energy industry is shifting from policy-driven growth to market-driven quality improvement, with Xiehe New Energy and Taikang's partnership representing a market-oriented response to this transition [6][8]. - The success of the new investment model will depend on the asset management capabilities of the industry partner and the patience of the funding partner in navigating the inherent volatility of the renewable energy sector [7][8].

Group 1 - The core point of the article is that Xiehe New Energy (00182) has announced the sale of its subsidiary, Cangzhou Julong Solar Power Co., Ltd., for approximately RMB 65.3 million, which is based on the company's asset value and business performance [1][2] - The sale involves a 100% equity transfer of a 50 MW solar power project located in Cangzhou, Hebei Province, with an unaudited net asset value of approximately RMB 26.08 million as of July 31, 2025 [1] - The payment for the sale will be made in three installments, with 70% paid upon completion of business registration and partial document transfer, 20% upon full document transfer and other conditions, and the remaining 10% after all project deficiencies are resolved [1] Group 2 - If the parties do not reach an agreement on issues before February 28, 2026, the seller has a buyback obligation and must return the paid price along with a 7% annual compensation [2] - The transaction constitutes a discloseable transaction as the combined applicable percentage exceeds 5% but is below 25%, thus requiring compliance with the listing rules [2]

New IPOs - Guoxia Technology (02655) received a subscription rate of 1890.73 times for its public offering in Hong Kong, with a share price of HKD 20.1 [1] - Easy Health (02661), Hansai Aitai-B (03378), and Nobi Kan (02635) are scheduled for public offerings from December 15 to December 18, with expected listing on December 23 [1] Major Events - Luoyang Molybdenum (03993) plans to acquire three major gold mining assets in Brazil for USD 1.015 billion [1] - Zhongwei New Materials (02579) has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect securities list [1] - Botai Carlink (02889) received a first project confirmation notice from a leading domestic new energy vehicle client [1] - Xiehe New Energy (00182) intends to sell 100% equity of Cangzhou Julong for CNY 65.3 million [1] - Fosun Pharma (02196) plans to invest a total of CNY 1.412 billion to gain control of Green Valley Pharmaceutical [1] - Youqu Holdings (02177) intends to spend JPY 2.701 billion to acquire the Japanese consulting pharmacy chain Akahige [1] Financial Data - China Metallurgical Group (01618) signed new contracts worth CNY 958.13 billion in the first 11 months, a decrease of 8.6% year-on-year [1] - Xinhua Insurance (01336) reported a cumulative original insurance premium income of CNY 188.85 billion in the first 11 months, an increase of 16% year-on-year [1] - China Southern Airlines (01055) saw a 10.42% year-on-year increase in passenger turnover in November [1] - China Shenhua (01088) reported coal sales of 389.5 million tons in the first 11 months, a decrease of 7.7% year-on-year [1] - China Eastern Airlines (00670) experienced a 10.35% year-on-year increase in passenger turnover in November [1] - Air China (00753) reported a 10.1% year-on-year increase in passenger turnover in November [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.051 million shares for HKD 636 million on December 15 [2] - Xiaomi Group-W (01810) repurchased 7.2 million shares for HKD 302 million on December 15 [2] - Geely Automobile (00175) repurchased 1.991 million shares for HKD 34.7485 million on December 15 [2] - Kuaishou-W (01024) repurchased 462,000 shares for HKD 29.9304 million on December 15 [2] - Rongchang Bio (09995) plans to repurchase shares worth between CNY 2 million and CNY 4 million [2] - Gendyn New Drug (01952) received over HKD 38 million in share purchases from directors and major shareholders [2]